Reviewed,
UniProtKB/Swiss-Prot Q05793 (PGBM_MOUSE)
Last modified
June 16, 2009.
Version 98.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Basement membrane-specific heparan sulfate proteoglycan core protein Short name=HSPG Alternative name(s): Perlecan Short name=PLC | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 3707 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | This protein is an integral component of basement membranes. It is responsible for the fixed negative electrostatic charge and is involved in the charge-selective ultrafiltration properties. It serves as an attachment substrate for cells. |
| Subunit structure | Purified perlecan has a strong tendency to aggregate in dimers or stellate structures. It interacts with other basement membrane components such as laminin, prolargin and collagen type IV. Interacts with COL13A1, FGFBP1 and VWA1. Ref.4 |
| Subcellular location | Secreted › extracellular space › extracellular matrix › basement membrane. |
| Tissue specificity | Found in the basement membranes. |
| Post-translational modification | Contains three heparan sulfate chains as well as N-linked and O-linked oligosaccharides. |
| Sequence similarities | Contains 1 EGF-like domain. Contains 15 Ig-like C2-type (immunoglobulin-like) domains. Contains 11 laminin EGF-like domains. Contains 3 laminin G-like domains. Contains 3 laminin IV type A domains. Contains 4 LDL-receptor class A domains. Contains 1 SEA domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | |||||||||||||||||||||||||
| Chain | 22 – 3707 | 3686 | Basement membrane-specific heparan sulfate proteoglycan core protein | PRO_0000026697 | ||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||
| Domain | 80 – 194 | 115 | SEA | |||||||||||||||||||||||||
| Domain | 195 – 234 | 40 | LDL-receptor class A 1 | |||||||||||||||||||||||||
| Domain | 281 – 319 | 39 | LDL-receptor class A 2 | |||||||||||||||||||||||||
| Domain | 320 – 359 | 40 | LDL-receptor class A 3 | |||||||||||||||||||||||||
| Domain | 360 – 403 | 44 | LDL-receptor class A 4 | |||||||||||||||||||||||||
| Domain | 404 – 504 | 101 | Ig-like C2-type 1 | |||||||||||||||||||||||||
| Domain | 521 – 530 | 10 | Laminin EGF-like 1; first part | |||||||||||||||||||||||||
| Domain | 538 – 730 | 193 | Laminin IV type A 1 | |||||||||||||||||||||||||
| Domain | 731 – 763 | 33 | Laminin EGF-like 1; second part | |||||||||||||||||||||||||
| Domain | 764 – 813 | 50 | Laminin EGF-like 2 | |||||||||||||||||||||||||
| Domain | 814 – 871 | 58 | Laminin EGF-like 3 | |||||||||||||||||||||||||
| Domain | 879 – 923 | 45 | Laminin EGF-like 4; truncated | |||||||||||||||||||||||||
| Domain | 924 – 933 | 10 | Laminin EGF-like 5; first part | |||||||||||||||||||||||||
| Domain | 941 – 1125 | 185 | Laminin IV type A 2 | |||||||||||||||||||||||||
| Domain | 1126 – 1158 | 33 | Laminin EGF-like 5; second part | |||||||||||||||||||||||||
| Domain | 1159 – 1208 | 50 | Laminin EGF-like 6 | |||||||||||||||||||||||||
| Domain | 1209 – 1265 | 57 | Laminin EGF-like 7 | |||||||||||||||||||||||||
| Domain | 1275 – 1324 | 50 | Laminin EGF-like 8 | |||||||||||||||||||||||||
| Domain | 1325 – 1334 | 10 | Laminin EGF-like 9; first part | |||||||||||||||||||||||||
| Domain | 1344 – 1529 | 186 | Laminin IV type A 3 | |||||||||||||||||||||||||
| Domain | 1530 – 1562 | 33 | Laminin EGF-like 9; second part | |||||||||||||||||||||||||
| Domain | 1563 – 1612 | 50 | Laminin EGF-like 10 | |||||||||||||||||||||||||
| Domain | 1613 – 1670 | 58 | Laminin EGF-like 11 | |||||||||||||||||||||||||
| Domain | 1677 – 1771 | 95 | Ig-like C2-type 2 | |||||||||||||||||||||||||
| Domain | 1772 – 1865 | 94 | Ig-like C2-type 3 | |||||||||||||||||||||||||
| Domain | 1866 – 1954 | 89 | Ig-like C2-type 4 | |||||||||||||||||||||||||
| Domain | 1955 – 2049 | 95 | Ig-like C2-type 5 | |||||||||||||||||||||||||
| Domain | 2050 – 2148 | 99 | Ig-like C2-type 6 | |||||||||||||||||||||||||
| Domain | 2149 – 2244 | 96 | Ig-like C2-type 7 | |||||||||||||||||||||||||
| Domain | 2245 – 2343 | 99 | Ig-like C2-type 8 | |||||||||||||||||||||||||
| Domain | 2344 – 2436 | 93 | Ig-like C2-type 9 | |||||||||||||||||||||||||
| Domain | 2437 – 2532 | 96 | Ig-like C2-type 10 | |||||||||||||||||||||||||
| Domain | 2533 – 2619 | 87 | Ig-like C2-type 11 | |||||||||||||||||||||||||
| Domain | 2620 – 2720 | 101 | Ig-like C2-type 12 | |||||||||||||||||||||||||
| Domain | 2721 – 2809 | 89 | Ig-like C2-type 13 | |||||||||||||||||||||||||
| Domain | 2810 – 2895 | 86 | Ig-like C2-type 14 | |||||||||||||||||||||||||
| Domain | 2896 – 2980 | 85 | Ig-like C2-type 15 | |||||||||||||||||||||||||
| Domain | 2984 – 3162 | 179 | Laminin G-like 1 | |||||||||||||||||||||||||
| Domain | 3163 – 3241 | 79 | EGF-like | |||||||||||||||||||||||||
| Domain | 3245 – 3425 | 181 | Laminin G-like 2 | |||||||||||||||||||||||||
| Domain | 3518 – 3705 | 188 | Laminin G-like 3 | |||||||||||||||||||||||||
| Region | 3615 – 3617 | 3 | Mediates motor neuron attachment Potential | |||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||
| Glycosylation | 65 | 1 | O-linked (Xyl...) (heparan sulfate) Potential | |||||||||||||||||||||||||
| Glycosylation | 71 | 1 | O-linked (Xyl...) (heparan sulfate) Potential | |||||||||||||||||||||||||
| Glycosylation | 76 | 1 | O-linked (Xyl...) (heparan sulfate) Potential | |||||||||||||||||||||||||
| Glycosylation | 89 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 358 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 554 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 1256 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 1891 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 2336 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 2394 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 2427 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 2600 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 3098 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 3154 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Glycosylation | 3385 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||
| Disulfide bond | 199 ↔ 212 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 206 ↔ 225 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 219 ↔ 234 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 285 ↔ 297 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 292 ↔ 310 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 304 ↔ 319 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 325 ↔ 337 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 332 ↔ 350 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 344 ↔ 359 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 368 ↔ 381 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 375 ↔ 394 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 388 ↔ 403 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 428 ↔ 479 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 764 ↔ 773 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 766 ↔ 780 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 783 ↔ 792 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 795 ↔ 811 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 814 ↔ 829 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 816 ↔ 839 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 842 ↔ 851 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 854 ↔ 869 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 879 ↔ 892 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 894 ↔ 903 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 906 ↔ 921 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1159 ↔ 1168 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1161 ↔ 1175 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1178 ↔ 1187 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1190 ↔ 1206 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1209 ↔ 1224 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1211 ↔ 1234 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1237 ↔ 1246 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1249 ↔ 1263 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1275 ↔ 1287 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1277 ↔ 1293 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1295 ↔ 1304 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1307 ↔ 1322 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1563 ↔ 1572 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1565 ↔ 1579 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1582 ↔ 1591 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1594 ↔ 1610 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1613 ↔ 1628 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1615 ↔ 1638 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1641 ↔ 1650 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1653 ↔ 1668 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1792 ↔ 1839 | |||||||||||||||||||||||||||
| Disulfide bond | 1886 ↔ 1932 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 1976 ↔ 2021 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2073 ↔ 2118 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2170 ↔ 2215 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2268 ↔ 2313 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2365 ↔ 2413 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2456 ↔ 2506 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2554 ↔ 2599 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2641 ↔ 2686 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2831 ↔ 2876 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 2917 ↔ 2962 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3137 ↔ 3163 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3166 ↔ 3177 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3171 ↔ 3187 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3204 ↔ 3216 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3229 ↔ 3238 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3393 ↔ 3419 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3425 ↔ 3436 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3430 ↔ 3446 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3448 ↔ 3457 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3464 ↔ 3476 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3470 ↔ 3481 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3483 ↔ 3492 | By similarity | ||||||||||||||||||||||||||
| Disulfide bond | 3671 ↔ 3705 | By similarity | ||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||
| Sequence conflict | 1192 | 1 | P → T AA sequence Ref.2 | |||||||||||||||||||||||||
| Sequence conflict | 1227 | 1 | D → L AA sequence Ref.2 | |||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||
| Beta strand | 1770 – 1774 | 5 | ||||||||||||||||||||||||||
| Beta strand | 1779 – 1782 | 4 | ||||||||||||||||||||||||||
| Beta strand | 1788 – 1799 | 12 | ||||||||||||||||||||||||||
| Beta strand | 1802 – 1807 | 6 | ||||||||||||||||||||||||||
| Helix | 1808 – 1810 | 3 | ||||||||||||||||||||||||||
| Beta strand | 1817 – 1820 | 4 | ||||||||||||||||||||||||||
| Beta strand | 1823 – 1826 | 4 | ||||||||||||||||||||||||||
| Helix | 1831 – 1833 | 3 | ||||||||||||||||||||||||||
| Beta strand | 1835 – 1842 | 8 | ||||||||||||||||||||||||||
| Beta strand | 1847 – 1856 | 10 | ||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule." Noonan D.M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., Hassell J.R. J. Biol. Chem. 266:22939-22947(1991) [PubMed: 1744087] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Melanoma. |
| [2] | "Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan." Noonan D.M., Horigan E.A., Ledbetter S.R., Vogeli G., Sasaki M., Yamada Y., Hassell J.R. J. Biol. Chem. 263:16379-16387(1988) [PubMed: 2972708] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 940-1601 AND 1870-2600, PARTIAL PROTEIN SEQUENCE. |
| [3] | "Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif." Schulze B., Mann K., Battistutta R., Wiedemann H., Timpl R. Eur. J. Biochem. 231:551-556(1995) [PubMed: 7649154] [Abstract] Cited for: PARTIAL PROTEIN SEQUENCE. |
| [4] | "WARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecan." Allen J.M., Bateman J.F., Hansen U., Wilson R., Bruckner P., Owens R.T., Sasaki T., Timpl R., Fitzgerald J. J. Biol. Chem. 281:7341-7349(2006) [PubMed: 16407285] [Abstract] Cited for: INTERACTION WITH VWA1. |
| [5] | "Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1." Hopf M., Gohring W., Ries A., Timpl R., Hohenester E. Nat. Struct. Biol. 8:634-640(2001) [PubMed: 11427896] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1761-1858 IN COMPLEX WITH A NIDOGEN FRAGMENT. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M77174 mRNA. Translation: AAA39911.1. J04054 mRNA. Translation: AAA39899.1. J04055 mRNA. Translation: AAA39912.1. | |||||||||||||
| IPI | IPI00113824. | ||||||||||||
| PIR | S18252. | ||||||||||||
| UniGene | Mm.273662 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q05793. 1 interaction. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q05793. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUSG00000028763. Mus musculus. [Contig view] | ||||||||||||
Organism-specific databases | |||||||||||||
| MGI | MGI:96257. Hspg2. | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | Q05793. | ||||||||||||
| HOVERGEN | Q05793. | ||||||||||||
Gene expression databases | |||||||||||||
| Bgee | Q05793. | ||||||||||||
| CleanEx | MM_HSPG2. | ||||||||||||
| GermOnline | ENSMUSG00000028763. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR013320. ConA-like_subgrp. IPR006209. EGF. IPR006210. EGF-like. IPR013032. EGF-like_reg_CS. IPR000742. EGF_3. IPR002049. EGF_laminin. IPR013151. Ig. IPR007110. Ig-like. IPR013783. Ig-like_fold. IPR013098. Ig_I-set. IPR003599. Ig_sub. IPR003598. Ig_sub2. IPR013106. Ig_V-set. IPR018031. Laminin_B. IPR000034. Laminin_B_type_IV. IPR001791. Laminin_G. IPR012679. Laminin_G_1. IPR012680. Laminin_G_2. IPR002172. LDL_rcpt_classA_cys-rich. IPR000082. SEA. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.60.120.200. ConA_like_subgrp. 3 hits. G3DSA:2.60.40.10. Ig-like_fold. 14 hits. G3DSA:4.10.400.10. LDL_rcpt_classA_cys-rich. 3 hits. | ||||||||||||
| Pfam | PF00008. EGF. 3 hits. PF07679. I-set. 8 hits. PF00047. ig. 6 hits. PF00052. Laminin_B. 3 hits. PF00053. Laminin_EGF. 8 hits. PF00054. Laminin_G_1. 1 hit. PF02210. Laminin_G_2. 2 hits. PF00057. Ldl_recept_a. 4 hits. PF01390. SEA. 1 hit. PF07686. V-set. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00261. LDLRECEPTOR. | ||||||||||||
| ProDom | PD003031. Laminin_B. 3 hits. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00181. EGF. 3 hits. SM00180. EGF_Lam. 7 hits. SM00409. IG. 1 hit. SM00408. IGc2. 14 hits. SM00281. LamB. 3 hits. SM00282. LamG. 3 hits. SM00192. LDLa. 4 hits. SM00200. SEA. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00022. EGF_1. 8 hits. PS01186. EGF_2. 5 hits. PS50026. EGF_3. 4 hits. PS01248. EGF_LAM_1. 11 hits. PS50027. EGF_LAM_2. 8 hits. PS50835. IG_LIKE. 15 hits. PS50025. LAM_G_DOMAIN. 3 hits. PS51115. LAMININ_IVA. 3 hits. PS01209. LDLRA_1. 4 hits. PS50068. LDLRA_2. 4 hits. PS50024. SEA. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | PGBM_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q05793 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


